Is Alt a good stock to buy?
There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Altimmune stock.
Will Alt stock go up?
Will Altimmune stock price grow / rise / go up? Yes. The ALT stock price can go up from 9.170 USD to 13.529 USD in one year.
What is the target price for Altimmune?
Stock Price Target ALT
How do I buy Altimmune stock?
How to buy shares in Altimmune
- Compare share trading platforms.
- Open and fund your brokerage account.
- Search for Altimmune.
- Purchase now or later.
- Decide on how many to buy.
- Check in on your investment.
Why did Altimmune stock drop?
Altimmune Inc. ALT, -1.02% shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn’t work as well as anticipated. Shares had gained 53% over the past 12 months, compared with a 41% gain on the S&P 500 index SPX, -0.10% .
Is Altimmune a good company?
Altimmune has been one of the top-performing stocks in our speculative portfolio. The company recently reported encouraging results from their NASH candidate, ALT-801. The market has been bullish on ALT since they announced their COVID-19 programs, but now it is time to turn our attention to ALT-801.
What kind of company is Altimmune?
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases and intranasal vaccines.
Why is Altimmune stock dropping?
Altimmune Inc. ALT, -0.23% shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn’t work as well as anticipated. Shares had gained 53% over the past 12 months, compared with a 41% gain on the S&P 500 index SPX, +0.14% .
Should you invest in altimmune (Alt) stock?
Investors need to pay close attention to Altimmune (ALT) stock based on the movements in the options market lately.
What does Alt stand for?
GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the 2021 Jefferies Virtual Healthcare Conference, being held June 1 – 4, 2021.
When is altimmune’s next quarterly earnings announcement?
Altimmune is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021. View our earnings forecast for Altimmune. How were Altimmune’s earnings last quarter? Altimmune, Inc. (NASDAQ:ALT) announced its earnings results on Monday, August, 9th.
Who sold aldalt stock in the last quarter?
ALT stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Goldman Sachs Group Inc., Cubist Systematic Strategies LLC, Principal Financial Group Inc., Parallax Volatility Advisers L.P., BNP Paribas Arbitrage SA, Wells Fargo & Company MN, and Rafferty Asset Management LLC.